Engineering a monobody specific to monomeric Cu/Zn‐superoxide dismutase associated with amyotrophic lateral sclerosis
Protein Science · 2024
DOI: 10.1002/pro.4961 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, 2024. Verfasst von Hiroshi Amesaka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomolecular Chemistry, Kyoto Prefectural University, Kyoto, Japan. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Grants-in-Aid for Scientific Research on Innovative Areas, Scientific Research (B), Ministry of Education, Culture, Sports, Science and Technology of Japan.
Abstract (Originalsprache)
Misfolding of mutant Cu/Zn‐superoxide dismutase (SOD1) has been implicated in familial form of amyotrophic lateral sclerosis (ALS). A natively folded SOD1 forms a tight homodimer, and the dimer dissociation has been proposed to trigger the oligomerization/aggregation of SOD1. Besides increasing demand for probes allowing the detection of monomerized forms of SOD1 in various applications, the development of probes has been limited to conventional antibodies. Here, we have developed Mb(S4) monobody, a small synthetic binding protein based on the fibronectin type III scaffold, that recognizes a monomeric but not dimeric form of SOD1 by performing combinatorial library selections using phage and yeast‐surface display methods. Although Mb(S4) was characterized by its excellent selectivity to the monomeric conformation of SOD1, the monomeric SOD1/Mb(S4) complex was not so stable (apparent K d ~ μM) as to be detected in conventional pull‐down experiments. Instead, the complex of Mb(S4) with monomeric but not dimeric SOD1 was successfully trapped by proximity‐enabled chemical crosslinking even when reacted in the cell lysates. We thus anticipate that Mb(S4) binding followed by chemical crosslinking would be a useful strategy for in vitro and also ex vivo detection of the monomeric SOD1 proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomolecular Chemistry, Kyoto Prefectural University, Kyoto, Japan.
- Department of Chemistry, Keio University, Yokohama, Japan.
- Department of Neuroscience of Disease, Brain Research Institute, Niigata University, Niigata, Japan.
ORCID-Profile: Shun-Ichi Tanaka, Yoshiaki Furukawa
Förderung
- Grants-in-Aid for Scientific Research on Innovative Areas
- Scientific Research (B)
- Ministry of Education, Culture, Sports, Science and Technology of Japan
Zitieren
APA
Amesaka, H., Hara, M., Sakai, Y., Shintani, A., Sue, K., Yamanaka, T., Tanaka, S. I., & Furukawa, Y. (2024). Engineering a monobody specific to monomeric Cu/Zn‐superoxide dismutase associated with amyotrophic lateral sclerosis. Protein Science. https://doi.org/10.1002/pro.4961
Vancouver
Amesaka H, Hara M, Sakai Y, Shintani A, Sue K, Yamanaka T, et al. Engineering a monobody specific to monomeric Cu/Zn‐superoxide dismutase associated with amyotrophic lateral sclerosis. Protein Science. 2024. doi:10.1002/pro.4961
BibTeX
@article{Amesaka2024,
author = {Amesaka, Hiroshi and Hara, Mizuho and Sakai, Yuki and Shintani, Atsuko and Sue, Kaori and Yamanaka, Tomoyuki and Tanaka, Shun-Ichi and Furukawa, Yoshiaki},
title = {Engineering a monobody specific to monomeric Cu/Zn‐superoxide dismutase associated with amyotrophic lateral sclerosis},
journal = {Protein Science},
year = {2024},
doi = {10.1002/pro.4961}
}
EUVIMED